US 10611760
Therapeutic compounds as inhibitors of the orexin-1 receptor
granted A61PA61P19/10A61P25/00
Quick answer
US patent 10611760 (Therapeutic compounds as inhibitors of the orexin-1 receptor) held by C4X Discovery Limited expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4X Discovery Limited
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P19/10, A61P25/00, A61P25/04, A61P25/06